Share Price and Basic Stock Data
Last Updated: January 19, 2026, 1:28 pm
| PEG Ratio | -12.86 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
Advance Petrochemicals Ltd operates in the inorganic chemicals sector, focusing on a diverse range of chemical products. The company’s reported sales have shown a fluctuating trend, with the latest figure for the trailing twelve months (TTM) standing at ₹46.85 Cr. This reflects a significant increase from ₹37.09 Cr recorded in Mar 2023, highlighting a robust growth trajectory. The quarterly sales for Sep 2023 were ₹8.19 Cr, slightly declining to ₹7.80 Cr in Dec 2023, before rebounding to ₹10.99 Cr in Mar 2024. This pattern indicates resilience amid market fluctuations. The company’s expense management has also been noteworthy, with total expenses for Mar 2025 reported at ₹48.43 Cr compared to ₹34.33 Cr in Mar 2023, demonstrating a need for ongoing scrutiny to sustain profitability levels. Overall, the revenue growth trajectory, coupled with the company’s strategic positioning in the chemical sector, underpins its operational viability.
Profitability and Efficiency Metrics
Profitability metrics for Advance Petrochemicals Ltd reveal a mixed performance, with a reported net profit of ₹0.04 Cr and an exceptionally high P/E ratio of 450. This suggests that while the market values the company highly, actual earnings remain subdued. The operating profit margin (OPM) stood at a low 2.75%, indicating challenges in maintaining pricing power amidst rising costs. Over the past few quarters, the OPM fluctuated significantly, peaking at 11.31% in Sep 2022 and declining to 0.97% by Jun 2023. The return on equity (ROE) reported at 7.71% and return on capital employed (ROCE) at 9.56% reflect moderate efficiency in capital utilization, although these figures are below the sector averages, which typically range higher. Additionally, the cash conversion cycle of 37.41 days indicates efficient working capital management, although the company must continue to improve profitability to enhance overall financial health.
Balance Sheet Strength and Financial Ratios
The balance sheet of Advance Petrochemicals Ltd reflects a leveraged position, with total borrowings reported at ₹12.72 Cr against reserves of ₹2.91 Cr. The debt-to-equity ratio stands at a concerning 2.75, indicating high financial risk compared to typical sector norms. This level of leverage can strain cash flows, particularly if operating profits remain low. The interest coverage ratio (ICR) of 2.26x suggests that while the company can meet its interest obligations, there is limited cushion for financial distress. The book value per share, which has shown an upward trend to ₹43.79 as of Mar 2025, provides a measure of the company’s net asset value, reassuring stakeholders of inherent value despite operational challenges. Furthermore, the current ratio of 1.02 indicates a balanced liquidity position, although it is marginally below the optimal threshold of 1.5 typically seen in the industry.
Shareholding Pattern and Investor Confidence
The shareholding pattern of Advance Petrochemicals Ltd indicates a stable promoter presence, with promoters holding 50.11% of the company’s shares as of Mar 2025. This reflects a commitment to the company’s long-term strategy. The public shareholding is 49.89%, showing a balanced distribution that can enhance liquidity. The number of shareholders has gradually increased to 2,145, suggesting growing interest among retail investors. However, the fluctuations in promoter shareholding, which declined to 44.32% in Jun 2023, may raise concerns about insider confidence. Investor sentiment could be influenced by the company’s profitability challenges and high P/E ratio, which might deter value-focused investors. Overall, the shareholding structure reflects a moderate level of investor confidence, but ongoing operational performance will be critical to maintaining this sentiment.
Outlook, Risks, and Final Insight
The outlook for Advance Petrochemicals Ltd hinges on its ability to navigate current profitability challenges and leverage its operational strengths. Key risks include its high leverage ratio, which may amplify financial distress, particularly if revenue growth does not translate into improved profitability. Additionally, the low operating profit margin could limit reinvestment capacity and shareholder returns. On the positive side, the company’s stable promoter holding and efficient working capital management present opportunities for recovery. The firm must focus on enhancing its operational efficiency and exploring avenues for revenue diversification to mitigate risks. Should the company successfully implement strategies to improve margins and manage debt, it could position itself favorably for sustainable growth. Conversely, failure to address these challenges may hinder its market potential and investor confidence.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Fischer Medical Ventures Ltd | 2,354 Cr. | 36.3 | 125/35.8 | 117 | 5.55 | 0.01 % | 1.08 % | 0.70 % | 1.00 |
| Emmessar Biotech & Nutrition Ltd | 14.0 Cr. | 28.1 | 45.9/25.8 | 61.0 | 16.0 | 0.00 % | 12.6 % | 4.23 % | 10.0 |
| Cochin Minerals & Rutile Ltd | 196 Cr. | 250 | 356/238 | 11.7 | 211 | 3.22 % | 23.3 % | 15.0 % | 10.0 |
| Archean Chemical Industries Ltd | 6,580 Cr. | 533 | 728/408 | 32.1 | 157 | 0.56 % | 16.0 % | 12.0 % | 2.00 |
| Alufluoride Ltd | 308 Cr. | 394 | 503/376 | 15.0 | 144 | 0.78 % | 23.6 % | 20.8 % | 10.0 |
| Industry Average | 4,634.38 Cr | 369.34 | 141.65 | 156.25 | 0.53% | 13.95% | 10.65% | 6.18 |
Quarterly Result
| Metric | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 9.28 | 10.01 | 7.97 | 8.21 | 8.19 | 7.80 | 10.99 | 10.80 | 11.25 | 12.72 | 15.16 | 9.51 | 9.46 |
| Expenses | 8.23 | 9.34 | 7.82 | 8.13 | 7.40 | 7.45 | 10.38 | 10.41 | 11.15 | 12.35 | 14.51 | 9.09 | 9.20 |
| Operating Profit | 1.05 | 0.67 | 0.15 | 0.08 | 0.79 | 0.35 | 0.61 | 0.39 | 0.10 | 0.37 | 0.65 | 0.42 | 0.26 |
| OPM % | 11.31% | 6.69% | 1.88% | 0.97% | 9.65% | 4.49% | 5.55% | 3.61% | 0.89% | 2.91% | 4.29% | 4.42% | 2.75% |
| Other Income | 0.07 | 0.05 | -0.03 | 0.01 | 0.00 | 0.01 | 0.03 | 0.02 | 0.34 | 0.01 | 0.04 | 0.02 | 0.02 |
| Interest | 0.19 | 0.18 | 0.18 | 0.20 | 0.21 | 0.21 | 0.23 | 0.22 | 0.25 | 0.20 | 0.18 | 0.27 | 0.37 |
| Depreciation | 0.12 | 0.12 | 0.43 | 0.20 | 0.20 | 0.20 | 0.10 | 0.17 | 0.17 | 0.17 | 0.08 | 0.15 | 0.15 |
| Profit before tax | 0.81 | 0.42 | -0.49 | -0.31 | 0.38 | -0.05 | 0.31 | 0.02 | 0.02 | 0.01 | 0.43 | 0.02 | -0.24 |
| Tax % | 43.21% | 23.81% | -16.33% | 0.00% | 5.26% | 0.00% | 25.81% | 0.00% | 0.00% | 100.00% | 39.53% | 0.00% | 0.00% |
| Net Profit | 0.46 | 0.31 | -0.41 | -0.31 | 0.37 | -0.05 | 0.23 | 0.01 | 0.02 | 0.00 | 0.27 | 0.01 | -0.24 |
| EPS in Rs | 5.11 | 3.44 | -4.56 | -3.44 | 4.11 | -0.56 | 2.56 | 0.11 | 0.22 | 0.00 | 3.00 | 0.11 | -2.67 |
Last Updated: December 28, 2025, 8:09 am
Below is a detailed analysis of the quarterly data for Advance Petrochemicals Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Sales, as of Sep 2025, the value is 9.46 Cr.. The value appears to be declining and may need further review. It has decreased from 9.51 Cr. (Jun 2025) to 9.46 Cr., marking a decrease of 0.05 Cr..
- For Expenses, as of Sep 2025, the value is 9.20 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 9.09 Cr. (Jun 2025) to 9.20 Cr., marking an increase of 0.11 Cr..
- For Operating Profit, as of Sep 2025, the value is 0.26 Cr.. The value appears to be declining and may need further review. It has decreased from 0.42 Cr. (Jun 2025) to 0.26 Cr., marking a decrease of 0.16 Cr..
- For OPM %, as of Sep 2025, the value is 2.75%. The value appears to be declining and may need further review. It has decreased from 4.42% (Jun 2025) to 2.75%, marking a decrease of 1.67%.
- For Other Income, as of Sep 2025, the value is 0.02 Cr.. The value remains steady. There is no change compared to the previous period (Jun 2025) which recorded 0.02 Cr..
- For Interest, as of Sep 2025, the value is 0.37 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 0.27 Cr. (Jun 2025) to 0.37 Cr., marking an increase of 0.10 Cr..
- For Depreciation, as of Sep 2025, the value is 0.15 Cr.. The value remains steady. There is no change compared to the previous period (Jun 2025) which recorded 0.15 Cr..
- For Profit before tax, as of Sep 2025, the value is -0.24 Cr.. The value appears to be declining and may need further review. It has decreased from 0.02 Cr. (Jun 2025) to -0.24 Cr., marking a decrease of 0.26 Cr..
- For Tax %, as of Sep 2025, the value is 0.00%. The value remains steady. There is no change compared to the previous period (Jun 2025) which recorded 0.00%.
- For Net Profit, as of Sep 2025, the value is -0.24 Cr.. The value appears to be declining and may need further review. It has decreased from 0.01 Cr. (Jun 2025) to -0.24 Cr., marking a decrease of 0.25 Cr..
- For EPS in Rs, as of Sep 2025, the value is -2.67. The value appears to be declining and may need further review. It has decreased from 0.11 (Jun 2025) to -2.67, marking a decrease of 2.78.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: December 15, 2025, 4:18 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 12.54 | 11.20 | 10.46 | 8.85 | 12.74 | 21.29 | 13.90 | 17.44 | 27.92 | 37.09 | 35.19 | 49.94 | 46.85 |
| Expenses | 12.00 | 10.42 | 9.62 | 7.97 | 11.90 | 20.31 | 12.99 | 16.25 | 26.42 | 34.33 | 33.36 | 48.43 | 45.15 |
| Operating Profit | 0.54 | 0.78 | 0.84 | 0.88 | 0.84 | 0.98 | 0.91 | 1.19 | 1.50 | 2.76 | 1.83 | 1.51 | 1.70 |
| OPM % | 4.31% | 6.96% | 8.03% | 9.94% | 6.59% | 4.60% | 6.55% | 6.82% | 5.37% | 7.44% | 5.20% | 3.02% | 3.63% |
| Other Income | 0.18 | 0.01 | 0.03 | 0.03 | 0.08 | 0.09 | 0.10 | 0.12 | 0.06 | 0.09 | 0.06 | 0.41 | 0.09 |
| Interest | 0.40 | 0.45 | 0.53 | 0.58 | 0.64 | 0.77 | 0.77 | 0.72 | 0.72 | 0.74 | 0.88 | 0.85 | 1.02 |
| Depreciation | 0.13 | 0.20 | 0.19 | 0.18 | 0.18 | 0.19 | 0.17 | 0.22 | 0.40 | 0.79 | 0.70 | 0.60 | 0.55 |
| Profit before tax | 0.19 | 0.14 | 0.15 | 0.15 | 0.10 | 0.11 | 0.07 | 0.37 | 0.44 | 1.32 | 0.31 | 0.47 | 0.22 |
| Tax % | 36.84% | 64.29% | 53.33% | 46.67% | 10.00% | 0.00% | 0.00% | 27.03% | 31.82% | 28.03% | 32.26% | 36.17% | |
| Net Profit | 0.12 | 0.06 | 0.07 | 0.09 | 0.08 | 0.11 | 0.07 | 0.28 | 0.30 | 0.94 | 0.22 | 0.30 | 0.04 |
| EPS in Rs | 1.33 | 0.67 | 0.78 | 1.00 | 0.89 | 1.22 | 0.78 | 3.11 | 3.33 | 10.44 | 2.44 | 3.33 | 0.44 |
| Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | -50.00% | 16.67% | 28.57% | -11.11% | 37.50% | -36.36% | 300.00% | 7.14% | 213.33% | -76.60% | 36.36% |
| Change in YoY Net Profit Growth (%) | 0.00% | 66.67% | 11.90% | -39.68% | 48.61% | -73.86% | 336.36% | -292.86% | 206.19% | -289.93% | 112.96% |
Advance Petrochemicals Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 16% |
| 5 Years: | 29% |
| 3 Years: | 21% |
| TTM: | 29% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 17% |
| 5 Years: | 34% |
| 3 Years: | -4% |
| TTM: | -46% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | 37% |
| 3 Years: | 27% |
| 1 Year: | -39% |
| Return on Equity | |
|---|---|
| 10 Years: | 10% |
| 5 Years: | 14% |
| 3 Years: | 14% |
| Last Year: | 8% |
Last Updated: September 5, 2025, 2:06 pm
Balance Sheet
Last Updated: December 10, 2025, 3:45 am
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 0.90 | 0.90 | 0.90 | 0.90 | 0.90 | 0.90 | 0.90 | 0.90 | 0.90 | 0.90 | 0.90 | 0.90 | 0.90 |
| Reserves | 0.63 | 0.68 | 0.75 | 0.84 | 0.92 | 1.03 | 1.10 | 1.38 | 1.67 | 2.62 | 2.84 | 3.14 | 2.91 |
| Borrowings | 3.40 | 4.34 | 5.24 | 5.01 | 6.27 | 6.38 | 6.63 | 7.36 | 6.98 | 7.18 | 8.98 | 10.85 | 12.72 |
| Other Liabilities | 2.07 | 2.17 | 1.51 | 1.84 | 2.61 | 3.25 | 2.08 | 3.14 | 5.89 | 5.02 | 9.94 | 10.45 | 6.34 |
| Total Liabilities | 7.00 | 8.09 | 8.40 | 8.59 | 10.70 | 11.56 | 10.71 | 12.78 | 15.44 | 15.72 | 22.66 | 25.34 | 22.87 |
| Fixed Assets | 1.57 | 1.82 | 1.91 | 1.79 | 2.06 | 1.81 | 1.65 | 2.65 | 3.45 | 5.00 | 5.76 | 5.17 | 4.88 |
| CWIP | 0.00 | 0.00 | 0.00 | 0.25 | 0.00 | 0.00 | 0.48 | 0.00 | 0.00 | 0.43 | 0.00 | 2.49 | 3.42 |
| Investments | 0.36 | 0.36 | 0.36 | 0.36 | 0.36 | 0.36 | 0.36 | 0.36 | 0.36 | 0.36 | 0.36 | 0.36 | 0.00 |
| Other Assets | 5.07 | 5.91 | 6.13 | 6.19 | 8.28 | 9.39 | 8.22 | 9.77 | 11.63 | 9.93 | 16.54 | 17.32 | 14.57 |
| Total Assets | 7.00 | 8.09 | 8.40 | 8.59 | 10.70 | 11.56 | 10.71 | 12.78 | 15.44 | 15.72 | 22.66 | 25.34 | 22.87 |
Below is a detailed analysis of the balance sheet data for Advance Petrochemicals Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 0.90 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.90 Cr..
- For Reserves, as of Sep 2025, the value is 2.91 Cr.. The value appears to be declining and may need further review. It has decreased from 3.14 Cr. (Mar 2025) to 2.91 Cr., marking a decrease of 0.23 Cr..
- For Borrowings, as of Sep 2025, the value is 12.72 Cr.. The value appears to be increasing, which may not be favorable. However, Borrowings exceed Reserves, which may signal higher financial risk. It has increased from 10.85 Cr. (Mar 2025) to 12.72 Cr., marking an increase of 1.87 Cr..
- For Other Liabilities, as of Sep 2025, the value is 6.34 Cr.. The value appears to be improving (decreasing). It has decreased from 10.45 Cr. (Mar 2025) to 6.34 Cr., marking a decrease of 4.11 Cr..
- For Total Liabilities, as of Sep 2025, the value is 22.87 Cr.. The value appears to be improving (decreasing). It has decreased from 25.34 Cr. (Mar 2025) to 22.87 Cr., marking a decrease of 2.47 Cr..
- For Fixed Assets, as of Sep 2025, the value is 4.88 Cr.. The value appears to be declining and may need further review. It has decreased from 5.17 Cr. (Mar 2025) to 4.88 Cr., marking a decrease of 0.29 Cr..
- For CWIP, as of Sep 2025, the value is 3.42 Cr.. The value appears strong and on an upward trend. It has increased from 2.49 Cr. (Mar 2025) to 3.42 Cr., marking an increase of 0.93 Cr..
- For Investments, as of Sep 2025, the value is 0.00 Cr.. The value appears to be declining and may need further review. It has decreased from 0.36 Cr. (Mar 2025) to 0.00 Cr., marking a decrease of 0.36 Cr..
- For Other Assets, as of Sep 2025, the value is 14.57 Cr.. The value appears to be declining and may need further review. It has decreased from 17.32 Cr. (Mar 2025) to 14.57 Cr., marking a decrease of 2.75 Cr..
- For Total Assets, as of Sep 2025, the value is 22.87 Cr.. The value appears to be declining and may need further review. It has decreased from 25.34 Cr. (Mar 2025) to 22.87 Cr., marking a decrease of 2.47 Cr..
However, the Borrowings (12.72 Cr.) are higher than the Reserves (2.91 Cr.), which may signal higher financial risk.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -2.86 | -3.56 | -4.40 | -4.13 | -5.43 | -5.40 | -5.72 | -6.17 | -5.48 | -4.42 | -7.15 | -9.34 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 61.71 | 73.98 | 80.26 | 51.97 | 53.00 | 41.83 | 32.30 | 53.16 | 63.93 | 35.92 | 93.56 | 70.97 |
| Inventory Days | 77.37 | 118.64 | 135.92 | 271.87 | 226.41 | 127.25 | 217.07 | 185.97 | 111.70 | 76.07 | 89.34 | 53.73 |
| Days Payable | 38.87 | 49.55 | 34.11 | 98.61 | 89.06 | 61.39 | 56.50 | 75.02 | 100.40 | 57.52 | 131.91 | 87.28 |
| Cash Conversion Cycle | 100.21 | 143.07 | 182.07 | 225.22 | 190.35 | 107.69 | 192.87 | 164.11 | 75.23 | 54.46 | 50.98 | 37.41 |
| Working Capital Days | 25.32 | 22.81 | 20.24 | 29.69 | 25.78 | 11.66 | 13.39 | 13.19 | 3.53 | -5.90 | 0.93 | -2.12 |
| ROCE % | 11.52% | 10.88% | 10.62% | 10.70% | 9.97% | 10.73% | 9.92% | 11.82% | 12.61% | 20.35% | 10.16% | 9.56% |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | 3.36 | 2.40 | 10.49 | 3.28 | 3.09 |
| Diluted EPS (Rs.) | 3.36 | 2.40 | 10.49 | 3.28 | 3.09 |
| Cash EPS (Rs.) | 10.00 | 10.12 | 19.28 | 7.75 | 5.51 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 43.79 | 40.43 | 38.03 | 27.54 | 24.25 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 44.86 | 41.50 | 39.10 | 28.61 | 25.32 |
| Revenue From Operations / Share (Rs.) | 554.84 | 390.97 | 412.12 | 310.20 | 193.80 |
| PBDIT / Share (Rs.) | 21.39 | 20.96 | 31.64 | 17.29 | 14.57 |
| PBIT / Share (Rs.) | 14.75 | 13.24 | 22.85 | 12.82 | 12.15 |
| PBT / Share (Rs.) | 5.28 | 3.48 | 14.62 | 4.84 | 4.17 |
| Net Profit / Share (Rs.) | 3.36 | 2.40 | 10.49 | 3.28 | 3.09 |
| PBDIT Margin (%) | 3.85 | 5.36 | 7.67 | 5.57 | 7.51 |
| PBIT Margin (%) | 2.65 | 3.38 | 5.54 | 4.13 | 6.26 |
| PBT Margin (%) | 0.95 | 0.88 | 3.54 | 1.56 | 2.15 |
| Net Profit Margin (%) | 0.60 | 0.61 | 2.54 | 1.05 | 1.59 |
| Return on Networth / Equity (%) | 7.66 | 5.93 | 27.59 | 11.92 | 12.76 |
| Return on Capital Employeed (%) | 15.20 | 16.84 | 35.07 | 24.49 | 21.89 |
| Return On Assets (%) | 1.19 | 0.95 | 6.00 | 1.91 | 2.17 |
| Long Term Debt / Equity (X) | 1.09 | 0.82 | 0.59 | 0.73 | 1.12 |
| Total Debt / Equity (X) | 2.75 | 2.47 | 2.10 | 2.75 | 3.36 |
| Asset Turnover Ratio (%) | 2.08 | 1.83 | 2.38 | 1.98 | 1.48 |
| Current Ratio (X) | 1.02 | 1.05 | 0.98 | 1.07 | 1.17 |
| Quick Ratio (X) | 0.67 | 0.65 | 0.45 | 0.52 | 0.40 |
| Inventory Turnover Ratio (X) | 8.29 | 6.18 | 4.37 | 3.22 | 2.10 |
| Interest Coverage Ratio (X) | 2.26 | 2.15 | 3.85 | 2.17 | 1.83 |
| Interest Coverage Ratio (Post Tax) (X) | 1.35 | 1.25 | 2.28 | 1.41 | 1.39 |
| Enterprise Value (Cr.) | 28.04 | 25.00 | 48.28 | 10.15 | 10.42 |
| EV / Net Operating Revenue (X) | 0.56 | 0.71 | 1.30 | 0.36 | 0.59 |
| EV / EBITDA (X) | 14.56 | 13.25 | 16.96 | 6.52 | 7.95 |
| MarketCap / Net Operating Revenue (X) | 0.35 | 0.47 | 1.12 | 0.13 | 0.19 |
| Price / BV (X) | 4.54 | 4.58 | 12.15 | 1.52 | 1.59 |
| Price / Net Operating Revenue (X) | 0.35 | 0.47 | 1.12 | 0.13 | 0.19 |
| EarningsYield | 0.01 | 0.01 | 0.02 | 0.07 | 0.08 |
After reviewing the key financial ratios for Advance Petrochemicals Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 3.36. This value is below the healthy minimum of 5. It has increased from 2.40 (Mar 24) to 3.36, marking an increase of 0.96.
- For Diluted EPS (Rs.), as of Mar 25, the value is 3.36. This value is below the healthy minimum of 5. It has increased from 2.40 (Mar 24) to 3.36, marking an increase of 0.96.
- For Cash EPS (Rs.), as of Mar 25, the value is 10.00. This value is within the healthy range. It has decreased from 10.12 (Mar 24) to 10.00, marking a decrease of 0.12.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 43.79. It has increased from 40.43 (Mar 24) to 43.79, marking an increase of 3.36.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 44.86. It has increased from 41.50 (Mar 24) to 44.86, marking an increase of 3.36.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 554.84. It has increased from 390.97 (Mar 24) to 554.84, marking an increase of 163.87.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 21.39. This value is within the healthy range. It has increased from 20.96 (Mar 24) to 21.39, marking an increase of 0.43.
- For PBIT / Share (Rs.), as of Mar 25, the value is 14.75. This value is within the healthy range. It has increased from 13.24 (Mar 24) to 14.75, marking an increase of 1.51.
- For PBT / Share (Rs.), as of Mar 25, the value is 5.28. This value is within the healthy range. It has increased from 3.48 (Mar 24) to 5.28, marking an increase of 1.80.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 3.36. This value is within the healthy range. It has increased from 2.40 (Mar 24) to 3.36, marking an increase of 0.96.
- For PBDIT Margin (%), as of Mar 25, the value is 3.85. This value is below the healthy minimum of 10. It has decreased from 5.36 (Mar 24) to 3.85, marking a decrease of 1.51.
- For PBIT Margin (%), as of Mar 25, the value is 2.65. This value is below the healthy minimum of 10. It has decreased from 3.38 (Mar 24) to 2.65, marking a decrease of 0.73.
- For PBT Margin (%), as of Mar 25, the value is 0.95. This value is below the healthy minimum of 10. It has increased from 0.88 (Mar 24) to 0.95, marking an increase of 0.07.
- For Net Profit Margin (%), as of Mar 25, the value is 0.60. This value is below the healthy minimum of 5. It has decreased from 0.61 (Mar 24) to 0.60, marking a decrease of 0.01.
- For Return on Networth / Equity (%), as of Mar 25, the value is 7.66. This value is below the healthy minimum of 15. It has increased from 5.93 (Mar 24) to 7.66, marking an increase of 1.73.
- For Return on Capital Employeed (%), as of Mar 25, the value is 15.20. This value is within the healthy range. It has decreased from 16.84 (Mar 24) to 15.20, marking a decrease of 1.64.
- For Return On Assets (%), as of Mar 25, the value is 1.19. This value is below the healthy minimum of 5. It has increased from 0.95 (Mar 24) to 1.19, marking an increase of 0.24.
- For Long Term Debt / Equity (X), as of Mar 25, the value is 1.09. This value exceeds the healthy maximum of 1. It has increased from 0.82 (Mar 24) to 1.09, marking an increase of 0.27.
- For Total Debt / Equity (X), as of Mar 25, the value is 2.75. This value exceeds the healthy maximum of 1. It has increased from 2.47 (Mar 24) to 2.75, marking an increase of 0.28.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 2.08. It has increased from 1.83 (Mar 24) to 2.08, marking an increase of 0.25.
- For Current Ratio (X), as of Mar 25, the value is 1.02. This value is below the healthy minimum of 1.5. It has decreased from 1.05 (Mar 24) to 1.02, marking a decrease of 0.03.
- For Quick Ratio (X), as of Mar 25, the value is 0.67. This value is below the healthy minimum of 1. It has increased from 0.65 (Mar 24) to 0.67, marking an increase of 0.02.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 8.29. This value exceeds the healthy maximum of 8. It has increased from 6.18 (Mar 24) to 8.29, marking an increase of 2.11.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 2.26. This value is below the healthy minimum of 3. It has increased from 2.15 (Mar 24) to 2.26, marking an increase of 0.11.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 1.35. This value is below the healthy minimum of 3. It has increased from 1.25 (Mar 24) to 1.35, marking an increase of 0.10.
- For Enterprise Value (Cr.), as of Mar 25, the value is 28.04. It has increased from 25.00 (Mar 24) to 28.04, marking an increase of 3.04.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 0.56. This value is below the healthy minimum of 1. It has decreased from 0.71 (Mar 24) to 0.56, marking a decrease of 0.15.
- For EV / EBITDA (X), as of Mar 25, the value is 14.56. This value is within the healthy range. It has increased from 13.25 (Mar 24) to 14.56, marking an increase of 1.31.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 0.35. This value is below the healthy minimum of 1. It has decreased from 0.47 (Mar 24) to 0.35, marking a decrease of 0.12.
- For Price / BV (X), as of Mar 25, the value is 4.54. This value exceeds the healthy maximum of 3. It has decreased from 4.58 (Mar 24) to 4.54, marking a decrease of 0.04.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 0.35. This value is below the healthy minimum of 1. It has decreased from 0.47 (Mar 24) to 0.35, marking a decrease of 0.12.
- For EarningsYield, as of Mar 25, the value is 0.01. This value is below the healthy minimum of 5. There is no change compared to the previous period (Mar 24) which recorded 0.01.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Advance Petrochemicals Ltd:
- Net Profit Margin: 0.6%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 15.2% (Industry Average ROCE: 13.95%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 7.66% (Industry Average ROE: 10.65%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 1.35
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 0.67
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 428 (Industry average Stock P/E: 141.65)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 2.75
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 0.6%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Chemicals - Inorganic - Others | 36, Kothari Market, Kankaria Road, Ahmedabad Gujarat 380022 | info@advancepetro.com http://www.advancepetro.com |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Pulkit Goenka | Chairman & Managing Director |
| Ms. Aanchal Arvind Goenka | Non Executive Woman Director |
| Mr. Akshat Shukla | Non Exe. & Ind. Director |
| Mr. Arvind Vishwanath Goenka | Non Executive Director |
| Mrs. Palak Tapas Relia | Non Executive Woman Director |
| Mr. Harshil B Vadodariya | Non Exe. & Ind. Director |
FAQ
What is the intrinsic value of Advance Petrochemicals Ltd?
Advance Petrochemicals Ltd's intrinsic value (as of 21 January 2026) is ₹759.85 which is 299.92% higher the current market price of ₹190.00, indicating undervalued. Calculated using the PE ratio method, this valuation considers the company's ₹17.1 Cr. market cap, FY2025-2026 high/low of ₹255/169, reserves of ₹2.91 Cr, and liabilities of ₹22.87 Cr.
What is the Market Cap of Advance Petrochemicals Ltd?
The Market Cap of Advance Petrochemicals Ltd is 17.1 Cr..
What is the current Stock Price of Advance Petrochemicals Ltd as on 21 January 2026?
The current stock price of Advance Petrochemicals Ltd as on 21 January 2026 is ₹190.
What is the High / Low of Advance Petrochemicals Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Advance Petrochemicals Ltd stocks is ₹255/169.
What is the Stock P/E of Advance Petrochemicals Ltd?
The Stock P/E of Advance Petrochemicals Ltd is 428.
What is the Book Value of Advance Petrochemicals Ltd?
The Book Value of Advance Petrochemicals Ltd is 42.3.
What is the Dividend Yield of Advance Petrochemicals Ltd?
The Dividend Yield of Advance Petrochemicals Ltd is 0.00 %.
What is the ROCE of Advance Petrochemicals Ltd?
The ROCE of Advance Petrochemicals Ltd is 9.56 %.
What is the ROE of Advance Petrochemicals Ltd?
The ROE of Advance Petrochemicals Ltd is 7.71 %.
What is the Face Value of Advance Petrochemicals Ltd?
The Face Value of Advance Petrochemicals Ltd is 10.0.